60274 240 mg Pill - blue & yellow capsule/oblong, 22mm
Pill with imprint 60274 240 mg is Blue & Yellow, Capsule/Oblong and has been identified as Verapamil Hydrochloride SR 240 mg. It is supplied by Watson Pharmaceuticals.
Verapamil is used in the treatment of Arrhythmia; Angina; High Blood Pressure; Headache; Migraine and belongs to the drug classes calcium channel blockers, group IV antiarrhythmics. Risk cannot be ruled out during pregnancy. Verapamil 240 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 60274 240 mg
Verapamil Hydrochloride SR
- Imprint
- 60274 240 mg
- Strength
- 240 mg
- Color
- Blue & Yellow
- Size
- 22.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Calcium channel blockers, Group IV antiarrhythmics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Pharmaceuticals
- Inactive Ingredients
-
fumaric acid,
magnesium silicate,
sucrose,
corn starch,
shellac,
FD&C Red No. 40,
ferric oxide yellow,
titanium dioxide,
methylparaben,
propylparaben,
silicon dioxide,
sodium lauryl sulfate,
FD&C Blue No. 1,
D&C Red No. 28
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
00591-2884 | Watson Pharmaceuticals, Inc. |
62175-0582 | Kremers Urban Pharmaceuticals Inc. |
More about verapamil
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (180)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: calcium channel blockers
- Breastfeeding
- En español
Patient resources
Other brands
Calan, Calan SR, Verelan, Covera-HS, ... +2 more
Professional resources
- Verapamil monograph
- Verapamil (FDA)
- Verapamil Extended Release Capsules (FDA)
- Verapamil Extended Release Tablets (FDA)
- Verapamil Hydrochloride PM (FDA)
Other brands
Calan, Calan SR, Verelan, Verelan PM
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.